Tender Details

Country: USA
Summary: Nei Translational Research Program For Therapeutics (R33 Clinical Trial Not Allowed)
UST Ref No: 112844769
Deadline: 16 Mar 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: USD 1000000
Notice Type: Tender
Document Ref. No.: PAR-25-363
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The Purpose Of This Nofo Is The Rapid And Efficient Translation Of Innovative Laboratory Research Findings Into Therapeutics For Use By Clinicians To Treat Visual System Diseases Or Disorders. Multidisciplinary Teams Of Scientists And Clinicians Must Focus On Generating Preclinical Data That Will Lead To The Development Of Biological, Pharmacological, Medical Device And/Or Combination Product Interventions. The Ultimate Goal Of This Program Is To Make New Technological, Biological And Pharmacological Resources Available To Clinicians And Their Patients. The Steps Towards This Goal Should Be Clearly Delineated In A Series Of Milestones That Support The Development Of A Therapeutic Or Device That Will Lead To An Investigational New Drug (Ind) Or Investigational Device Exception (Ide) Application To The U.S. Food And Drug Administration (Fda) And/Or Testing In A Clinical Trial. The R33 Is To Focus On Advancing A Single Therapeutic Candidate Through Ind/Ide -Enabling Studies, Filing An Ind Package With The Fda, And Designing Future Clinical Trials. Applicants Pursuing Early Stage Applied Research Should Consider The Companion (R61/R33) Nofo Pa-23-Xxx.
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Nei Translational Research Program For Therapeutics (R33 Clinical Trial Not Allowed) - USA Tender

The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Nei Translational Research Program For Therapeutics (R33 Clinical Trial Not Allowed). This tender is published on USARFP under UST Ref No: 112844769 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-16.

The estimated tender value is USD 1000000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.